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ABSTRACT
In this work, we report electrospun nanofibers made of model hydrophobic (poly(lactide-co-ε-caprolactone); 
PLCL) and hydrophilic (gelatin) polymers. We explored the effect of the incorporation of sodium bicarbonate (SB)
into these fibres on drug release, using the potent antibacterial agent ciprofloxacin as a model drug. The fibers
prepared are smooth and have relatively uniform diameters lying between ca. 600 and 900 nm. The presence of
ciprofloxacin in the fibers was confirmed using IR spectroscopy. X-ray diffraction showed the drug to be
incorporated into the fibers in the amorphous form. In vitro drug release studies found that, as expected, more
rapid drug release was seen with gelatin fibers than those made of PLCL, and a greater final release percentage
was obtained. The inclusion of SB in the gelatin fibers imparts them with pH sensitivity: gelatin/SB fibers showed
faster release at pH 5 than pH 7, while fibers without SB gave the same release profiles at both pHs. The PLCL
fibers have no pH sensitivity, even when SB was included, as a result of their hydrophobic structure precluding
the ingress of solvent. In vitro cell culture studies showed that all the fibers are able to promote cell proliferation.
The ciprofloxacin loaded fibers are effective in inhibiting Eschericha coli and Staphylococcus aureus growth in
antibacterial tests. Thus, the gelatin-based fibers can be used as pH-responsive drug delivery systems, with
potential applications for instance in the treatment of tumor resection sites. Should these become infected, the pH
would drop, resulting in ciprofloxacin being released and the infection halted.
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1. Introduction
Nanoscale fibers have been increasingly explored in recent years. There are many approaches available for
2preparing these, such as template polymerization, self-assembly, phase separation, and electrostatic spinning. The
latter has attracted particular attention for the preparation of nanofiber materials because of its simplicity, low cost,
possessing porous, high surface area to volume ratios and the wide variety of materials which can be processed [1,
2]. Nano- and micro-scale fibers find use in a range of areas including catalysis, environmental remediation, and
for the delivery of active pharmaceutical ingredients [3]. Electrospinning has attracted particular attention for
biomedical applications mainly due to growing interest in nano-technologies, and the attractive material properties
which can be obtained (e.g. porosity, flexibility) [4]. For instance, researchers have explored the use of drug-
loaded electrospun fibers for the treatment or prevention of cancer. Ranganath et al. [5] prepared a electrospun
poly(lactic-co-glycolic acid) nanofibers loaded with the anti-cancer drug paclitaxel, and found them to be
effective against glioma tumors in vivo. In other work, Liu et al. [6] prepared electrospun fibers containing sodium
dichloroacetate and found these to lead to the necrosis of tumor cells, resulting in a inhibition rate of up to 96%.
Tissue engineering, such as for the nerve, has also been widely explored [7].
An ideal drug delivery system (DDS) must be both safe and effective, and should also offer a specific
delivery pattern. This might comprise site-specific drug delivery or extended release, for instance. Electrospun
fibers have great promise in this regard. To achieve the desired release properties, the choice of polymer to be
used requires careful consideration. A fast-dissolving polymer will give higher release than an insoluble material,
but the solubility of the drug in the polymer is also important. In a study by Natu and co-workers [8],
acetazolamide and timolol maleate-loaded fibers of poly(ε-caprolactone) and poly(oxyethylene-b-oxypropylene-b-
oxyethylene) were prepared by blend electrospinning. Maleate was released faster than acetazolamide. High drug
loadings, where crystals of the active ingredients were present, showed a greater burst release and faster release
rate than low drug content fibers where the drug was spread evenly throughout the (slow-dissolving) polymer.
Both the fiber composition and drug solubility in the polymer clearly influenced the release profiles seen.
Fibers can also be electrospun from stimuli-responsive materials, for instance those that change their
properties with a change in temperature [9] or pH. The latter is particularly important given the changes in pH
which occur as a formulation taken orally passes through the human gastrointestinal tract, and differences
between the physiological pH and that of the tumor microenvironment. A number of pH-sensitive drug delivery
systems generated by electrospinning have been reported. For example, Aguilar et al. [10] prepared composite
mats of polyurethane and the pH-sensitive polymer Eudragit® L100-55, loaded with paclitaxel by electrospinning.
In vitro drug release, analyzed by high performance liquid chromatography, showed the composite mats give slow
release of paclitaxel at pH 4, and relatively rapid release at pH 6. Adopting a different approach, Zhao and co-
workers [11] developed an acid-responsive nanofiber scaffold using electrospinning. The fibers comprised
poly(L-lactic acid) loaded with sodium bicarbonate and ketoprofen. In acidic conditions, sodium bicarbonate
reacts with protons to form CO2 gas, accelerating drug release. This reaction with acid can be used to generate
pores in the fiber, and thus permit a drug cargo to diffuse easily into solution. In contrast, at neutral pH the SB is
stable, and thus the fiber remains non-porous and impermeable. In this way, pH sensitivity can be achieved
without the need for bespoke polymers, allowing a much wider range of responsive systems to be developed.
Our ability to treat and cure cancer has improved tremendously in recent years [12]. However, there are still
numerous deaths from cancer every year, and thus the search for new and more effective therapies continues.
Surgical removal of the tumor is perhaps the “gold standard” treatment, where the growth is accessible. This
comes with potential problems though: for instance, the operation may cause an inflammatory reaction, which in
3turn can lead to the recurrence of the tumor [13]. This reaction is also associated with a lowering of the local
tissue pH, and thus a pH-responsive system might be beneficial here [14].
In this study, we report electrospun fibers developed using sodium bicarbonate (SB) as a pH-responsive
component. We explored the ability of SB to impart pH sensitivity on two polymers which do not normally
possess this: gelatin and poly(lactide-co-ε-caprolactone).  These are respectively model hydrophilic and 
hydrophobic polymers, and this is the first time that the ability of sodium bicarbonate to induce pH-sensitivity in
analogous nanofibers of differing hydrophilicity has been. The ultimate aim of this work is to develop novel anti-
tumor therapeutics.
Gelatin is a hydrophilic natural biopolymer. It has been widely used in food, medicine and cosmetic
applications as well as in biomaterials [15, 16], and is the major structural protein in animal skin and bones.
Gelatin has very good biological compatibility, and thus is attractive as a potential drug carrier [17]. However,
gelatin dissolves quickly into aqueous media (regardless of pH), and thus although gelatin fibers can be prepared
by electrospinning they undergo very rapid release unless some post-fabrication modification is performed.
Approaches to ameliorate this issue include using a layer-by-layer approach to combine multiple polymers in a
single system. For instance, Mandal et al. [18] prepared a silk fibroin/gelatin multilayer film and were able to
control the release of the drug incorporated. Such a fabrication process is relatively complex though, and a simple
option would be advantageous. Here, we opted to simply cross-link the gelatin molecules in the fibers after their
fabrication, using glutaraldehyde as a crosslinking agent [19]. Zhang and co-workers have previously
demonstrated the utility of this approach by employing a saturated glutaraldehyde vapor to improve the
thermostability and mechanical properties of gelatin nanofibers [20].
Poly(lactide-co-ε-caprolactone) (PLCL) is a hydrophobic aliphatic polyester copolymer. It has the 
advantages of good biocompatibility, a lack of toxicity in vivo, and high mechanical strength. It is also easy to
process by electrospinning, and PLCL products have been explored in tissue engineering, and for wound dressings,
drug delivery, and so forth [21, 22].
The model drug ciprofloxacin was loaded into both the PLCL and gelatin systems being explored.
Ciprofloxacin is a third generation quinolone, with broad-spectrum antibacterial activity [23, 24]. By developing
novel pH-responsive nanofiber membranes containing ciprofloxacin, we hoped to develop scaffolds which
ultimately might be used after tumour resection surgery. A detailed comparison of the drug release from
hydrophobic PLCL and hydrophilic gelatin-based fibers is reported, and their potential applications studied.
2. Experimental
2.1. Materials
Gelatin (powder, purity > 99.5%) was supplied by the Sinopharm Chemical Reagent Co., Ltd), while
dimethyl sulfoxide (DMSO) was sourced from J&K Chemicals. Dulbecco’s Modified Eagle Medium (DMEM)
was provided from Jinuo Biological Medicine Technology Ltd. Poly(lactide-co-ε-caprolactone) (PLCL, 
PCL:PLLA=1:1) came from Jinan Daigang Biomaterials. 1,1,1,3,3,3-Hexafluoroisopropanol (HFIP, purity >
95.5%), ciprofloxacin (purity > 98%), phosphate-buffered saline (PBS, sodium phosphate=10 mM, NaCl=150
mM; pH=7.4), sodium bicarbonate (SB, powder, purity > 99.5%), penicillin/streptomycin, thiazolyl blue
tetrazolium bromide (MTT) were supplied by Sigma-Aldrich Ltd. L929 cells were purchased from the Chinese
4Institute of Biochemistry and Cell Biology. An acetic acid buffer (AA, sodium acetate=25 mM; pH=5.0) was
prepared in-house. All other chemicals were at least analytical grade, and water was doubly distilled prior to use.
2.2. Electrospinning
Gelatin or PLCL were dissolved in hexafluoroisopropanol (HFIP) with SB, as detailed in Table 1.
Ciprofloxacin was added into selected solutions at a drug to polymer ratio of 1:9 (w/w). The solutions were
magnetically stirred in closed glass bottles sealed with parafilm at room temperature for 24 h. They were then
loaded into a 5 mL plastic syringes fitted with a stainless steel spinneret (internal diameter 0.5 mm). A syringe
pump (KDS100, Cole-Parmer) was used to drive the working fluids, at a flow rate of 0.8 mL/h. The
electrospinning process was carried out with a high voltage power supply (ZGF-2000, Shanghai Sute Electrical
Co. Ltd.) used to provide a potential difference of 15 kV between the spinneret and collector plate. The latter had
dimensions of 8 × 9 cm and was covered in aluminum foil. The distance between the spinneret and aluminum
foil was 23 cm. Experiments were performed at 20-25 ºC, and 33-45% relative humidity. The electrospun
products were dried in a vacuum chamber (DZF-6050, Shanghai Laboratory Instrument Work Co. Ltd.) for two
days at 25 ºC. After that, the gelatin fibers were crosslinked using an aqueous glutaraldehyde solution (25.0 –
28.0% (v/v)) to render them insoluble in water. The glutaraldehyde solution (10 mL) was placed at the bottom of
a brown translucent desiccator, and the fiber samples placed in a Petri dish and mounted on a rack above this
solution for approximately 8 h. All further experiments were performed on cross-linked fibers in the case of
gelatin.
Table 1. Details of the electrospinning solutions used in this study.
Fiber ID Gelatin conc (w/v) PLCL conc (w/v) SB conc (w/v) Ciprofloxacin conc (w/v)
G+ 15% - - 10%
G- 15% - - -
GS+ 15% - 5% 10%
GS- 15% - 5% -
P+ - 5% - 10%
P- - 5% - -
PS+ - 5% 5% 10%
PS- - 5% 5% -
2.3. Fiber morphology
The morphological structure of the nanofibers was characterized by scanning electron microscopy (SEM;
JSM-5600 LV microscope, JEOL) at a voltage of 10 kV. Sections of the fiber mats (1 × 0.5 cm) were cut, and
sputter coated with platinum for ca. 30 s before SEM was performed. The diameters of the fibers were then
measured using the ImageJ software (National Institutes of Health): ca. 50 fibers from each formulation were
randomly selected for measurement. The formulations were also examined by transmission electron microscopy
(TEM, H-800 instrument, Hitachi). Samples for TEM were directly electrospun onto copper grids.
2.4. Additional fiber characterization
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(Nicolet Instrument Corporation) over the range 500–4000 cm-1 and with a resolution of 2 cm-1. X-Ray
diffraction (XRD) patterns were collected over 5-60° on a D/Max-BR diffractometer (Rigaku) supplied with Cu
Kα radiation (40 kV/30 mA, λ = 1.5418 Å). 
Water contact angles were used to quantify the hydrophilic-hydrophobic properties of the fibers. 15 circular
cover slips (diameter ca. 14 mm) were placed on the aluminum foil covered collector plate, and fibers
electrospun onto them for approximately 7 h. After drying in a vacuum drying oven, the fiber coated cover slips
were used to determine contact angles using a 322W instrument (Thermo Cahn). A water droplet (ca. 2 µL) was
placed onto the surface of the fibers at room temperature, and digital images recorded. At least three samples of
each formulation were assessed, and three measurements made for each sample. Contact angles were quantified
immediately after the water droplet had come into contact with the fibers.
2.5. In vitro drug release
0.1 g of the ciprofloxacin-loaded fibers were placed in a centrifuge tube with 20 mL of PBS (pH 7.4) or AA
(pH 5.0) buffer solution. The centrifuge tubes were incubated in a constant temperature shaker (37 ºC, 100 rpm)
for one week. During this time, 1.0 mL of the release medium was periodically removed and 1.0 mL of fresh
pre-warmed PBS or AA solution added to keep the volume constant. The concentration of ciprofloxacin was
quantified at 277 nm using a UV-vis spectrometer (UV-1800, SHJH Company). Experiments were undertaken in
triplicate, and the results are reported as mean ± S.D.
2.6. Antibacterial activity
The antibacterial activity of the fibers was determined using the zone of inhibition test. 105 colony forming
units exemplar Gram-negative (Eschericha coli; ATCC 29522) and Gram-positive (Staphylococcus aureus;
ATCC 6538), were separately cultured on lauria broth. The pH of the liquid broth was adjusted to 6.8, then 100
µL aliquots of the bacterial suspensions were poured into Petri dishes (9 cm in diameter). The dishes were rested
for 10 minutes. Circular samples (diameter ca. 14 mm) cut from the fiber mat were added to the plates.
Incubation then proceeded for three days at 37 ºC, after which inhibition zones were measured. Experiments
were undertaken in triplicate, and the results are reported as mean ± S.D.
2.7. In vitro cytotoxicity experiments
The in vitro cytotoxicity of the fiber membranes was tested using the MTT (thiazolyl blue tetrazolium
bromide) assay. L929 fibroblast cells were cultivated in complete DMEM (DMEM supplemented with 10% (v/v)
inactivated fetal bovine serum, and 1% (v/v) penicillin-streptomycin solution (100 units/mL)) at 37 ºC. Fiber-
coated circular cover slips (prepared as for the contact angle experiments) were placed in the wells of a 24-well
plate. The plates were sterilized under UV irradiation for 2 h, then in alcohol steam for 6 h. Before use, they
were washed with PBS three times to remove any residual alcohol. Each well was augmented with 400 μL of 
complete DMEM and incubated (5% CO2, 37 ºC) for ca. 2 h.
The L929 cells in culture underwent trypsinization to remove them from the culture flask, after which they
were counted and resuspended at 2 × 104 cells/mL. 200 µL of these dissociated L929 cells were added to each
well of the plate, which was incubated (37 ºC, 5 % CO2) for 1, 3 or 5 days. After incubation, the DMEM solution
6was removed, the wells washed twice with PBS, and 40 μL of the MTT reagent solution (0.5% (w/v) in PBS) 
and 360 μL of DMEM added. The plates were incubated (37 ºC, 5 % CO2) for approximately 4 h, after which the
fluid in the wells was aspirated and replaced with 400 µL of DMSO. The plates were placed on a shaker for 30
min, then transferred into a 96 well plate. The optical density at 570 nm was quantified with a microplate reader
(Multiskan, Thermo-Fisher). Three independent experiments were performed, with triplicates in each.
3. Results and discussion
3.1. Fiber morphology
The morphology of all the fibers was studied by SEM and TEM. The images obtained are shown in Fig. 1
and Fig. S1 (Supporting Information). SEM reveals that all the fibers are cylindrical in shape, and their surfaces
are uniform and largely smooth. The gelatin (G-) and PLCL (P-) fiber diameters are 662±121 nm and 803±157
nm, respectively, while the gelatin/SB (GS-) and PLCL/SB (PS-) are essentially the same at 637±146 nm and
844±122 nm. The presence of SB thus has no marked effect on diameter. The drug-loaded G+ and P+ analogues
have diameters somewhat smaller than the drug-free systems: 603±128 nm and 732±130 nm (see Fig. S1). This
is also true for materials made up of gelatin/SB/ciprofloxacin (GS+) and PLCL/SB/ciprofloxacin (PS+), which
have diameters of 625±125 nm and 798±123 nm (see Fig. 1). This is expected to be because the addition of
ciprofloxacin increases the conductivity of the electrospinning solution.
Fig. 1(e) and (f) show the SEM images of GS- and GS+ after cross-linking. The fibers’ morphology has
barely changed, but their diameters have become larger. The same effect is seen for the SB-free systems G-
and G+ (Fig. S1), and can possibly be attributed to the formation of aldimine linkages (CH=N). TEM images
(Fig. 1(g)-(j)) show the fibers to comprise monolithic structures, with no core/shell structure, as would be
expected from a single fluid electrospinning experiment.
7Fig. 1. SEM and TEM images of the fibers generated. SEM images are given for (a) GS-; (b) GS+; (c) PS-; (d)
PS+; (e) GS- after cross-linking; and (f) GS+ after cross-linking, together with the fiber diameter distributions (a’-
f’). TEM images are presented for: (g) GS-; (h) GS+; (i) PS-; and (j) PS+. The scale bar in the SEM images
represents 10 μm. 
3.2. Further characterization
The XRD patterns and FT-IR spectra of gelatin, PLCL, ciprofloxacin and the different fibers are presented
in Fig. 2. The XRD data in Fig 2(a) show that PLCL is semi-crystalline, with two Bragg reflections. The gelatin
XRD pattern confirms it to be an amorphous material, with no reflections visible and only the broad humps
typical of amorphous systems. Ciprofloxacin exhibits numerous reflections in its XRD pattern, and thus it is
clearly a crystalline material [25, 26]. The PLCL formulations have the peaks of the polymer in their XRD
patterns, but no additional features can be seen. The gelatin fibers show no Bragg reflections in their patterns,
only broad humps. Thus, the ciprofloxacin is incorporated into the fibers in the amorphous physical form by dint
of the very rapid nature of the electrospinning process [27].
FT-IR spectra are given in Fig 2(b). Gelatin shows peaks at 3293 cm-1 (H-bonded -OH stretching), 1658 cm-
1 (C=O stretching; amide I band) and 1538 cm-1 (bending of N-H and stretching of C-N; amide II) [28]. PLCL
8has key vibrations at 1760 cm-1 which arise from ester bonds (-C(=O)O-), and at 2940 cm-1 from methylene (-
CH2) groups [29, 30]. The spectrum of ciprofloxacin displays characteristic peaks at 1599 cm-1 and 1499 cm-1,
corresponding to benzene ring stretching vibrations, carboxylate stretching at 1620 cm-1, and bands at 1090 cm-1
from the stretching of C-F, and at 3049 cm-1 from O-H stretching [31]. The spectra of the drug-free GS- and PS-
fibers show the same features as the raw polymer. GS+ and PS+ have very similar spectra to the pure polymer,
but with an additional peak at 1090 cm-1 and (in the case of PS+) 1620 cm-1 indicating the successful
incorporation of ciprofloxacin into gelatin or PLCL, respectively.
Fig. 2. (a) XRD patterns and (b) FT-IR spectra of gelatin, PLCL, ciprofloxacin and selected fibers.
Contact-angle data and images obtained immediately after addition of the water droplet to the fiber surface
are presented in Fig. 3 and Table 2. As described in the literature [32, 33], the gelatin nanofiber membranes
have hydrophilic surfaces, with contact angles below 40º. In contrast, the PLCL fibers are hydrophobic and have
high contact angles > 100º. The addition of the hydrophilic ciprofloxacin reduced the contact angle for both the
gelatin and PLCL fibers. The contact angles also decrease slightly with the addition of SB.
Fig. 3. Water contact angles of gelatin and PLCL nanofiber membranes: (a) GS-; (b) GS+; (c) PS-; (d) PS+.
9Table 2. The contact angles of the fibers.
Sample Contact-angle Sample Contact-angle
GS- 34±3.0° G- 33±3.1°
GS+ 25±2.7° G+ 21±2.3°
PS- 120±3.7° P- 119±4.8°
PS+ 105±2.6° P+ 110±5.2°
3.3. In vitro ciprofloxacin release and antibacterial activity
Fig. 4 and Fig. S2 illustrate the in vitro ciprofloxacin release profiles in PBS (pH 7.4) or AA (pH 5.0) at 37
°C. The SB-free G+ fibers and P+ fibers have very similar release profiles in AA and PBS, with no pH sensitivity
(Fig. S2), with a burst release of around 15% at the start of the experiment, and then sustained release over 30 –
50 h. The GS+ fibers exhibit a burst of release in the first 6 h, and the total amounts of ciprofloxacin released
reached 79.8% and 58.5% after incubation for 29 h in AA and PBS, respectively. There is clear pH sensitivity
visible in the release profiles. The PS+ fibers also show a burst release, but this is much reduced over that noted
with GS+. The total release amounts reached 46.1% and 46.9% after incubation for 45 h in AA and PBS, with the
release profiles in both conditions being essentially superimposable. The total amount of ciprofloxacin
released from the gelatin fibers is higher than that from the PLCL fibers, which is believed to be because
ciprofloxacin releases more easily from a hydrophilic material than a hydrophobic material [34].
The SB-containing gelatin fibers showed clear pH sensitivity, with acidic conditions promoting
ciprofloxacin release. This is expected to be because of the release of CO2 gas when SB reacts with protons,
therefore creating channels inside the fibers, forming a porous structure, and promoting more ciprofloxacin
release. SEM images were collected to assess this hypothesis, and are shown in Fig. 5. Many particles, believed
to be drug [35], can be seen on the surface of the GS+ fibers, particularly after immersion in the AA buffer
solution. This confirms the reaction of SB from within the fibers with protons in the release milieu, with this
effect being much greater with the acidic AA buffer. However, the PLCL fibers show very few solid particles on
their surfaces. We presume this is because the hydrophobic nature of the fibers makes it very difficult for the
buffer solution to penetrate into the fibers, and thus the SB has little opportunity to react and generate CO2.
Clearly, the inclusion of SB alone is not sufficient to impart pH sensitivity, and the properties of the polymer are
also crucial here. The pH-sensitive properties of the GS+ fibers might make them suitable to be implanted after
tumor resection to help prevent infection and the recurrence of cancer.
10
Fig. 4. In vitro ciprofloxacin release profiles from GS+ and PS+ fibers in PBS (pH 7.4) or AA (pH 5.0) buffer
solution.
Fig. 5. SEM images of GS+ and PS+ after immersion in PBS (pH 7.4) ((a), (b)) or AA (pH 5.0) ((c), (d)) for 24
hours. Scale bar: 10 μm. 
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Bacterial inhibition tests were used to evaluate the antibacterial activity of the ciprofloxacin released from
the fibers against Eschericha coli and Staphylococcus aureus. The results can be found in Fig. 6 and Table 3.
Clearly, the drug-free fibers have no antibacterial efficacy. In contrast, both the ciprofloxacin-containing fibers
showed antibacterial activity, with inhibition zones of 26-42 mm. The zone with GS+ was larger than that with
PS+. This is expected to be because a greater percentage of the drug is free from the gelatin fibers, as revealed
from the in vitro drug release experiments. The addition of SB also resulted in an increased diameter of the
inhibitory zone. The inhibition zones against Staphylococcus aureus are larger than with Eschericha coli,
consistent with the literature [36].
Fig. 6. The antibacterial properties of the different fibers: (a, a’) GS+; (b, b’) GS-; (c, c’) PS+; (d, d’) PS-.
Representative images from three times experiments are shown, with inhibition zones quantified as mean ± S.D.
from all experiments. Scale bar: 20 mm.
Table 3. Inhibition zone diameters for the fibers.
Sample
Inhibition zone with
Eschericha coli (mm)
Inhibition zone with
Staphylococcus aureus (mm)
GS+ 36±3.7 38±3.5
G+ 35±2.5 36±2.9
PS+ 31±3.5 32±1.9
P+ 28±2.1 31±3.4
GS- - -
G- - -
PS- - -
P- - -
3.4. Biocompatibility
The results of MTT cell viability measurements for the gelatin and PLCL nanofibers are given in Fig. 7
and Fig. S3. Evidently, the number of cells increases continuously from day 1 to day 5 in all cases. These
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results indicate that L929 cells can proliferate on both the gelatin and PLCL fibers, with no indication of any
toxicity. In general, L929 fiber cells grow faster on the gelatin fibers than on the PLCL fibers, presumably
because the former is a natural and hydrophilic material. The addition of ciprofloxacin did not change the
biocompatibility of the fibers. Cell growth on GS+ and PS+ (Fig. 7) is greater than on GS- and PS- (Fig. S3).
This is thought to be because SB increased the wettability of the fibers, which promotes cell growth. In all
cases, the viability with the fibers is at least on a par with the untreated cells control, confirming that all the
fibers have high biocompatibility.
Fig. 7. The viability of L929 cells exposed to selected fibers. Data from three independent experiments are given,
with 3 replicates per experiment, and are reported as mean ± S.D.
4. Conclusions
A series of nanofibers were prepared comprising gelatin or PLCL doped with sodium bicarbonate (SB).
Drug-loaded fibers containing the antibacterial ciprofloxacin were also produced. Electron microscopy
demonstrated that all the fibers are cylindrical monoliths with smooth and uniform surfaces. IR spectroscopy
verified the presence of the ciprofloxacin in the fibers, while XRD revealed the drug to be incorporated in the
amorphous form. All the gelatin fibers are hydrophilic while those of PLCL are hydrophobic, but in both cases
the inclusion of SB or ciprofloxacin increases the wettability. The hydrophilic gelatin-based fibers release
ciprofloxacin more rapidly than the hydrophobic PLCL analogues. The gelatin/SB fibers show pH sensitivity,
with more rapid release at lower pH owing to reaction of SB with protons in the acidic environment. SB-free
gelatin fibers have no such sensitivity. The PLCL systems also have no pH-sensitivity, regardless of the presence
or absence of SB. All the drug-loaded fibers had antibacterial activity, and were found to be highly
biocompatible with L929 cells. The gelatin fibers have greater antibacterial activities, and also biocompatibility,
than the PLCL systems. Overall, the new systems prepared in this work have great potential as drug delivery
systems. The pH-sensitive properties of the gelatin/SB fibers might render them suitable as a dosage form for
implantation after tumor resection, to prevent infection.
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